Halıt Karaca

1.2k total citations
52 papers, 839 citations indexed

About

Halıt Karaca is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Halıt Karaca has authored 52 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 8 papers in Epidemiology. Recurrent topics in Halıt Karaca's work include Gastric Cancer Management and Outcomes (7 papers), Renal cell carcinoma treatment (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Halıt Karaca is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Renal cell carcinoma treatment (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). Halıt Karaca collaborates with scholars based in Türkiye, United States and Belgium. Halıt Karaca's co-authors include Velı Berk, Mahmut Akpek, Nihat Kalay, Ali Ergin, Metin Özkan, Mustafa Dikilitaş, Metin Özkan, Ersin Özaslan, Mevlüde İnanç and Mikail Yarlıoğlueş and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and European Journal of Heart Failure.

In The Last Decade

Halıt Karaca

50 papers receiving 818 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Halıt Karaca Türkiye 13 422 373 275 100 94 52 839
Gülten Tekuzman Türkiye 15 334 0.8× 234 0.6× 171 0.6× 111 1.1× 59 0.6× 58 737
Anjali Desai United States 11 364 0.9× 410 1.1× 191 0.7× 84 0.8× 41 0.4× 40 796
M.T. Meinardi Netherlands 9 346 0.8× 578 1.5× 195 0.7× 145 1.4× 117 1.2× 10 1.0k
Massimo Maffezzini Italy 22 377 0.9× 173 0.5× 446 1.6× 199 2.0× 38 0.4× 110 2.0k
Sebastian Szmit Poland 16 238 0.6× 585 1.6× 296 1.1× 94 0.9× 155 1.6× 88 901
Ali Doğan Türkiye 15 452 1.1× 850 2.3× 206 0.7× 74 0.7× 155 1.6× 49 1.2k
Maria Albertsson Sweden 17 504 1.2× 132 0.4× 260 0.9× 46 0.5× 56 0.6× 35 877
Margot K. Davis Canada 16 364 0.9× 417 1.1× 188 0.7× 241 2.4× 90 1.0× 54 1.0k
Leslie R. Ellis United States 15 383 0.9× 545 1.5× 164 0.6× 318 3.2× 300 3.2× 48 1.5k
Ф. Т. Агеев Russia 11 354 0.8× 530 1.4× 112 0.4× 90 0.9× 125 1.3× 122 850

Countries citing papers authored by Halıt Karaca

Since Specialization
Citations

This map shows the geographic impact of Halıt Karaca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Halıt Karaca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Halıt Karaca more than expected).

Fields of papers citing papers by Halıt Karaca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Halıt Karaca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Halıt Karaca. The network helps show where Halıt Karaca may publish in the future.

Co-authorship network of co-authors of Halıt Karaca

This figure shows the co-authorship network connecting the top 25 collaborators of Halıt Karaca. A scholar is included among the top collaborators of Halıt Karaca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Halıt Karaca. Halıt Karaca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
İnanç, Mehmet Tuğrul, Metin Aytekin, Ayşe Ocak Duran, et al.. (2016). The relationship between plasma hyaluronan levels and anthracycline-related cardiotoxicity in breast cancer patients. International Journal of Cardiology. 218. 246–251. 2 indexed citations
3.
Bozkurt, Oktay, Serkan Şenol, Ayşe Ocak Duran, et al.. (2015). Primary Pleomorphic Rhabdomyosarcoma of Thyroid Gland in an Adult Patient: A Case Report. Eurasian Journal of Medicine. 48(1). 69–72. 6 indexed citations
4.
Cihan, Yasemin Benderli, et al.. (2014). ERCC1 as a Biological Marker Guiding Management in Malignant Pleural Mesothelioma. Asian Pacific Journal of Cancer Prevention. 15(10). 4117–4123. 8 indexed citations
5.
Mutlu, Hasan, Şeyda Gündüz, Halıt Karaca, et al.. (2014). Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: a multicenter retrospective study. Medical Oncology. 31(8). 74–74. 5 indexed citations
6.
Karaca, Halıt, Oktay Bozkurt, Ersin Özaslan, et al.. (2014). Positive Effects of Oral β-Glucan on Mucositis and Leukopenia in Colorectal Cancer Patients Receiving Adjuvant FOLFOX-4 Combination Chemotherapy. Asian Pacific Journal of Cancer Prevention. 15(8). 3641–3644. 17 indexed citations
7.
Keklık, Muzaffer, Serdar Şıvgın, Kemal Denız, et al.. (2013). Coincidence of three solid tumors in a patient with multiple myeloma. Chinese Medical Journal. 126(6). 1186–1187. 2 indexed citations
8.
Kefeli, Umut, Murat Akyol, Ramazan Yıldız, et al.. (2013). Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience.. PubMed. 60(124). 647–52. 4 indexed citations
9.
10.
Çoşkun, Uğur, Mevlüde İnanç, Tülay Akman, et al.. (2013). Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab. Oncology Research and Treatment. 36(10). 554–558. 2 indexed citations
11.
Mutlu, Hasan, Abdullah Büyükçelik, Halıt Karaca, et al.. (2013). Secondline Chemotherapy Versus Best Supportive Care in Patient with Malignant Pleural Mesothelioma: A Retrospective Study. Asian Pacific Journal of Cancer Prevention. 14(6). 3887–3889. 5 indexed citations
12.
İnanç, Mevlüde, Metin Özkan, Halıt Karaca, et al.. (2013). Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer. Medical Oncology. 31(1). 801–801. 51 indexed citations
13.
Mutlu, Hasan, et al.. (2013). Should FISH Test be Performed to all Patients With Breast Cancer?. SHILAP Revista de lepidopterología. 2(2). 539–539. 3 indexed citations
14.
Yıldız, Ramazan, Mustafa Beneklı, Metin Özkan, et al.. (2012). Bevacizumab every 4 weeks is as effective as every 2 weeks in combination with biweekly FOLFIRI in metastatic colorectal cancer. Journal of Cancer Research and Clinical Oncology. 138(11). 1845–1852. 4 indexed citations
15.
Berk, Velı, Hayati Demiraslan, Halıt Karaca, et al.. (2012). Moxifloxacin-associated neutropenia. Scandinavian Journal of Infectious Diseases. 45(5). 415–416. 4 indexed citations
16.
Eroğlu, Celalettin, et al.. (2012). The effect of being overweight on survival in patients with gastric cancer undergoing adjuvant chemoradiotherapy. European Journal of Cancer Care. 22(1). 133–140. 9 indexed citations
17.
Karaca, Halıt, et al.. (2009). The prevalence of primary hereditary hemochromatosis in central Anatolia. The Turkish Journal of Gastroenterology. 24(1). 43–50. 2 indexed citations
18.
Karaca, Halıt, et al.. (2009). Recovery of paraneoplastic hypercalcemia by sunitinib treatment for renal cell carcinoma: a case report and review of the literature. Medical Oncology. 27(3). 1023–1026. 10 indexed citations
19.
Sipahioğlu, Murat Hayri, Esra Sağlam, Oktay Oymak, et al.. (2005). Effect of Cyclosporine A on Total Homocysteine Level in a Rabbit Model. Transplantation Proceedings. 37(5). 2371–2374. 4 indexed citations
20.
Öner, Naci, et al.. (2004). Bone mineral metabolism changes in epileptic children receiving valproic acid. Journal of Paediatrics and Child Health. 40(8). 470–473. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gülten Tekuzman Breakdown of academic impact, for papers by Anjali Desai Breakdown of academic impact, for papers by M.T. Meinardi Breakdown of academic impact, for papers by Massimo Maffezzini Breakdown of academic impact, for papers by Sebastian Szmit Breakdown of academic impact, for papers by Ali Doğan Breakdown of academic impact, for papers by Maria Albertsson Breakdown of academic impact, for papers by Margot K. Davis Breakdown of academic impact, for papers by Leslie R. Ellis Breakdown of academic impact, for papers by Ф. Т. Агеев
Rankless by CCL
2026